AFC
DGX icon

Ares Financial Consulting’s Quest Diagnostics DGX Stock Holding History

Ares Financial Consulting’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.05K Hold
38
– – 0.01% 613
2026
Q1 		$7.51K Hold
38
– – 0.01% 608
2025
Q4 		$6.59K Buy
+38
New +$6.92K 0.01% 423

Other funds holding DGX

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM

Ares Financial Consulting's DGX Position: Q2 2026 in Review

Ares Financial Consulting held its Quest Diagnostics (DGX) position steady in Q2 2026 at 38 shares worth $8.05K. The position accounts for 0.01% of the portfolio, ranked #613.

Ares Financial Consulting first reported a position in DGX in Q4 2025 and has held it in 3 quarters since. 578 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Ares Financial Consulting held 38 shares of Quest Diagnostics worth $8.05K as of Q2 2026.
  • Ares Financial Consulting left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #613 holding.
  • Ares Financial Consulting first reported a position in Quest Diagnostics in Q4 2025 and has held it in 3 quarters since.
  • 578 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.